[1]
KAVITHA M and RONALD DARWIN C 2026. NETWORK PHARMACOLOGY-GUIDED TARGET IDENTIFICATION OF CADAMBINE AND DERIVATIVES FROM NEOLAMARCKIA CADAMBA AGAINST ALZHEIMER’S DISEASE WITH IN SILICO ADMET PROFILING. Asian Journal of Pharmaceutical and Clinical Research. 19, 4 (Apr. 2026), 144–157. DOI:https://doi.org/10.22159/ajpcr.2026v19i4.57815.